Kathryn Lurain , Talal El Zarif , Ramya Ramaswami , Amin H. Nassar , Elio Adib , Noha Abdel-Wahab , Nikita Chintapally , Claire E. Drolen , Tatyana Feldman , Tarek Haykal , Caroline A. Nebhan , Swetha Kambhampati , Mingjia Li , Arjun Mittra , Michael Lorentsen , Chul Kim , Alexandra Drakaki , Michael Morse , Douglas B. Johnson , Ankit Mangla , Alex F. Herrera
{"title":"PD-1阻断剂治疗HIV相关典型霍奇金淋巴瘤的真实世界多中心研究 \"的更正[《临床淋巴瘤、骨髓瘤和白血病》第24卷第8期,2024年8月,第523-530页]","authors":"Kathryn Lurain , Talal El Zarif , Ramya Ramaswami , Amin H. Nassar , Elio Adib , Noha Abdel-Wahab , Nikita Chintapally , Claire E. Drolen , Tatyana Feldman , Tarek Haykal , Caroline A. Nebhan , Swetha Kambhampati , Mingjia Li , Arjun Mittra , Michael Lorentsen , Chul Kim , Alexandra Drakaki , Michael Morse , Douglas B. Johnson , Ankit Mangla , Alex F. Herrera","doi":"10.1016/j.clml.2024.10.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 12","pages":"Page 873"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530]\",\"authors\":\"Kathryn Lurain , Talal El Zarif , Ramya Ramaswami , Amin H. Nassar , Elio Adib , Noha Abdel-Wahab , Nikita Chintapally , Claire E. Drolen , Tatyana Feldman , Tarek Haykal , Caroline A. Nebhan , Swetha Kambhampati , Mingjia Li , Arjun Mittra , Michael Lorentsen , Chul Kim , Alexandra Drakaki , Michael Morse , Douglas B. Johnson , Ankit Mangla , Alex F. Herrera\",\"doi\":\"10.1016/j.clml.2024.10.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"24 12\",\"pages\":\"Page 873\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-11-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265024023826\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265024023826","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530]
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.